Wall Street Zen Downgrades Orthofix Medical (NASDAQ:OFIX) to Hold

Key Points

• Wall Street Zen downgraded Orthofix Medical (NASDAQ:OFIX) from a "buy" to a "hold"; analysts overall are split (3 Buy, 2 Hold, 1 Sell) with a consensus Hold rating and an average price target of $17.25.
• The stock opened at $11.91 (1‑year range $10.24–$16.99) and the company reported negative EPS (‑$0.06 last quarter), negative ROE/net margin, and is forecast to post ‑1.57 EPS for the current year with a market cap of about $478M.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a research report issued to clients and investors on Saturday.

A number of other analysts have also weighed in on OFIX. Barrington Research reissued an "outperform" rating and issued a $17.00 price objective on shares of Orthofix Medical in a research report on Friday, April 10th. Canaccord Genuity Group dropped their target price on shares of Orthofix Medical from $24.00 to $20.00 and set a "buy" rating on the stock in a research note on Thursday, February 26th. Weiss Ratings restated a "sell (d-)" rating on shares of Orthofix Medical in a research note on Tuesday, April 21st. Stifel Nicolaus dropped their target price on shares of Orthofix Medical from $22.00 to $18.00 and set a "buy" rating on the stock in a research note on Monday, March 9th. Finally, TD Cowen assumed coverage on shares of Orthofix Medical in a research note on Tuesday, January 27th. They issued a "hold" rating and a $14.00 target price on the stock. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $17.25.

Orthofix Medical Stock Performance

Orthofix Medical stock opened at $11.91 on Friday. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.45 and a quick ratio of 1.43. Orthofix Medical has a 1-year low of $10.24 and a 1-year high of $16.99. The firm has a market capitalization of $478.07 million, a P/E ratio of -5.09 and a beta of 0.79. The company's 50-day moving average is $12.27 and its 200 day moving average is $13.96.

Orthofix Medical (NASDAQ:OFIX - Get Free Report) last posted its quarterly earnings data on Saturday, February 14th. The medical device company reported ($0.06) earnings per share for the quarter. Orthofix Medical had a negative return on equity of 20.38% and a negative net margin of 11.21%.The firm had revenue of $219.91 million during the quarter. Research analysts forecast that Orthofix Medical will post -1.57 EPS for the current year.

Insider Buying and Selling at Orthofix Medical

In other Orthofix Medical news, insider Lucas Vitale sold 4,269 shares of the stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $11.92, for a total transaction of $50,886.48. Following the sale, the insider owned 160,449 shares of the company's stock, valued at approximately $1,912,552.08. This trade represents a 2.59% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Engine Capital Management, Lp bought 13,061 shares of the company's stock in a transaction on Wednesday, February 25th. The shares were bought at an average cost of $12.96 per share, for a total transaction of $169,270.56. Following the transaction, the insider directly owned 3,673,092 shares in the company, valued at approximately $47,603,272.32. This represents a 0.36% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 1.30% of the company's stock.

Institutional Trading of Orthofix Medical

Hedge funds and other institutional investors have recently bought and sold shares of the stock. CWM LLC boosted its position in Orthofix Medical by 99.0% during the 3rd quarter. CWM LLC now owns 1,920 shares of the medical device company's stock valued at $28,000 after acquiring an additional 955 shares in the last quarter. State of Alaska Department of Revenue acquired a new stake in Orthofix Medical in the third quarter valued at approximately $30,000. Kestra Advisory Services LLC acquired a new stake in Orthofix Medical in the fourth quarter valued at approximately $56,000. Strs Ohio acquired a new stake in Orthofix Medical in the first quarter valued at approximately $150,000. Finally, Mackenzie Financial Corp acquired a new stake in Orthofix Medical in the third quarter valued at approximately $148,000. Institutional investors own 89.76% of the company's stock.

About Orthofix Medical

Orthofix Medical Inc NASDAQ: OFIX is a global medical device company focused on the design and development of innovative orthopedic and spinal solutions. The company's core business is divided into two segments: spine and orthopedics. In the spine segment, Orthofix offers a range of titanium implants, biologics and portable bone growth stimulation devices designed to support spinal fusion, deformity correction and minimally invasive procedures. Its orthopedic segment encompasses products for fracture fixation, external fixation systems, trauma care and sports medicine, providing surgeons with implantable devices and instruments for complex bone reconstruction and healing.

Orthofix's product portfolio includes strut systems, bone growth stimulators, interbody fusion devices and fixation hardware that address various indications such as degenerative disc disease, spinal deformities, non-unions and long-bone fractures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.